Researchers turn Salmonella into anti-viral gene therapy agent
UC Berkeley researchers have converted Salmonella bacteria from a foodborne pathogen into a safe delivery vehicle for anti-viral agents. They inserted virus-stopping ribozymes into Salmonella that had their ability to cause disease disabled, and then used the bacteria to effectively treat mice infected with cytomegalovirus. It is the first time bacteria have been successfully engineered to treat a viral infection.